Table of Content - H2 Receptor Antagonist Market

The H2 receptor antagonist Market is estimated to be valued at USD 4.21 Bn in 2024 and is expected to reach USD 6.36 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

H2 receptor antagonists are a group of pharmaceuticals that work by blocking the action of histamine at the histamine H2 receptors of the parietal cells in the stomach. By blocking this action, they reduce the production of acid by parietal cells and are thus used to treat conditions where reduced acid in the stomach is desirable. Some common conditions treated with H2 receptor antagonists include treatment and prevention of ulcers, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. H2 receptor antagonists are also commonly used in combination with antibiotics to treat gastric and duodenal ulcers. Major classes of H2 receptor antagonists include cimetidine, famotidine, nizatidine, and ranitidine.

Market Dynamics:

The global H2 receptor antagonist market is primarily driven by the rising prevalence of acid peptic disorders and gastric ulcers worldwide. According to the National Institute of Diabetes and Digestive and Kidney Diseases, over 5 million Americans experience heartburn once in a month. Additionally, long term use of NSAIDs for arthritis and other pain conditions has also increased the risk of gastric ulcers, thereby fueling the demand for acid reducers such as H2 receptor antagonists. However, the market growth can be restrained by the preference of proton pump inhibitors over H2 blockers owing to their higher efficacy and relatively lower dosage requirement. The development of novel H2 receptor antagonist drugs with enhanced potency and less frequent dosing schedules presents lucrative opportunities for market players.

Key Features of the Study:

This report provides an in-depth analysis of the global H2 receptor antagonist market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global H2 receptor antagonist market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include GlaxoSmithKline (GSK), Pfizer Inc., Johnson & Johnson, Boehringer Ingelheim, Abbott Laboratories, Teva Pharmaceutical Industries, Mylan N.V., Dr. Reddy's Laboratories, Cipla, Lupin Ltd., Sun Pharmaceutical Industries Pvt. Ltd., Cadila Healthcare, Hikma Pharmaceuticals, Novartis AG, Apotex Inc., Accord Healthcare, Aurobindo Pharma and Torrent Pharma Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global H2 receptor antagonist market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global H2 receptor antagonist market

Detailed Segmentation:

By Drug Type:
- Famotidine
- Ranitidine
- Nizatidine
- Cimetidine
- Others
By Dosage Form:
- Tablets
- Capsules
- Liquids
- Powders
- Others
By Indication:
- Gastroesophageal Reflux Disease (GERD)
- Peptic Ulcers
- Zollinger-Ellison Syndrome
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AstraZeneca
- GlaxoSmithKline (GSK)
- Pfizer Inc.
- Johnson & Johnson
- Boehringer Ingelheim
- Abbott Laboratories
- Teva Pharmaceutical Industries
- Mylan N.V.
- Reddy's Laboratories
- Cipla
- Lupin Ltd.
- Sun Pharmaceutical Industries Pvt. Ltd.
- Cadila Healthcare
- Hikma Pharmaceuticals
- Novartis AG
- Apotex Inc.
- Accord Healthcare
- Aurobindo Pharma
- Torrent Pharma Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
Market Overview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot By Drug Type
  - Market Snapshot By Dosage Form
  - Market Snapshot By Indication
  - Market Snapshot By Distribution Channel
  - Market Snapshot By Region
  - Market Scenario - Conservative, Like, Opportunistic
  - Market Opportunity Map
Key Insights
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Pest Analysis
- Porters Analysis
- Technological Advancement
- Merger, Acquisition and Collaboration Scenario
- Recent Product Approvals
- Regulatory Scenario
- Pricing Analysis
- COVID-19 Impact Analysis
- Route of Administration Analysis
- Reimbursement Scenario
- Manufacturing Capacities
Global H2 Receptor Antagonist Market, By Drug Type, 2019 - 2031 (US$ Billion)
- Introduction
  - Market Share (%) Analysis, 2024, 2027 & 2031
  - Market Y-o-Y Growth Comparison (%), 2020 - 2031
  - Segment Trends
- Famotidine, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Ranitidine, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Nizatidine, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Cimetidine, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Others, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
Global H2 Receptor Antagonist Market, By Dosage Form, 2019 - 2031 (US$ Billion)
- Introduction
  - Market Share (%) Analysis, 2024, 2027 & 2031
  - Market Y-o-Y Growth Comparison (%), 2020 - 2031
  - Segment Trends
- Tablets, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Capsules, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Liquids, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Powders, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Others, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
Global H2 Receptor Antagonist Market, By Indication, 2019 - 2031 (US$ Billion)
- Introduction
  - Market Share (%) Analysis, 2024, 2027 & 2031
  - Market Y-o-Y Growth Comparison (%), 2020 - 2031
  - Segment Trends
- Gastroesophageal Reflux Disease (GERD), 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Peptic Ulcers, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Zollinger-Ellison Syndrome, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Others, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
Global H2 Receptor Antagonist Market, By Distribution Channel, 2019 - 2031 (US$ Billion)
- Introduction
  - Market Share (%) Analysis, 2024, 2027 & 2031
  - Market Y-o-Y Growth Comparison (%), 2020 - 2031
  - Segment Trends
- Online Pharmacies, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Retail Pharmacies, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
- Hospital Pharmacies, 2019 - 2031(US$ Billion)
  - Introduction
  - Market Size and Forecast, 2019 - 2031, (US$ Billion)
Global H2 Receptor Antagonist Market, By Region, 2019 - 2031 (US$ Billion)
- Introduction
  - Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
  - Market Y-o-Y Growth Comparison (%), 2020 - 2031, (US$ Billion)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Dosage Form, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Dosage Form, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest Of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Dosage Form, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - Asean
    - Rest Of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Dosage Form, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest Of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Dosage Form, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
    - GCC
    - Israel
    - Rest Of The Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Drug Type, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Dosage Form, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Indication, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
  - Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
    - South Africa
    - North Africa
    - Central Africa
Company Profiles - Global H2 Receptor Antagonist Market
- AstraZeneca*
  - Company Overview
  - Product/Service Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategic Overview
- GlaxoSmithKline (GSK)
- Pfizer Inc.
- Johnson & Johnson
- Boehringer Ingelheim
- Abbott Laboratories
- Teva Pharmaceutical Industries
- Mylan N.V.
- Dr. Reddy's Laboratories
- Cipla
- Lupin Ltd.
- Sun Pharmaceutical Industries Pvt. Ltd.
- Cadila Healthcare
- Hikma Pharmaceuticals
- Novartis AG
- Apotex Inc.
- Accord Healthcare
- Aurobindo Pharma
- Torrent Pharma Inc.
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount